| Management target | Revenue 65.0% FY27 |
|---|
| Revenue growth | 60–70% target for FY27. |
|---|---|
| Margins | Targeting 30% EBITDA margins by FY27. |
| Order book | Export orders expected soon; government procurement contracts in place. |
| Demand visibility | Strong domestic presence; expanding into Brazil and South Africa. |
| Management confidence | High; expanding to D2/D3 facilities and international markets. |
Growth
FY26 Revenue ₹13,741.57 Cr; EBITDA ₹5,150.85 Cr; Net Profit ₹3,429.65 Cr.
Outlook
Targeting 60–70% revenue growth by FY27 with 30% EBITDA margins and 25% export contribution.
Risks
Fluctuating latex raw material prices and dependence on external suppliers for raw materials.
Earnings Call filed with NSE, NSE: ANONDITA. Summary written with AI assistance from the document.
Anondita Medicare Ltd: key numbers
- Share price
- ₹1,150.25
- Market cap
- ₹2,191 Cr
- Revenue (annual)
- ₹137.4 Cr
- Net profit (annual)
- ₹33.45 Cr
- P/E (TTM)
- 65.5×Sector 43.4×
- Promoter holding
- 62.40%
- FII holding
- 3.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anondita Medicare Ltd
All →Anondita Medicare Capital Structure Change
Anondita Medicare Limited has reinstated its previous rights issue corrigendum. The issue size is now confirmed at 9,58,166 equity shares, aggregating to ₹91.03 Crore.
- Value
- ₹91.03 Cr
Anondita Medicare Capital Structure Change
Anondita Medicare Limited issued a corrigendum to its Rights Issue, revising the total issue size to ₹91.03 Crore and adjusting the allocation for general corporate purposes.
- Value
- ₹91.03 Cr
Anondita Medicare Other Announcement
Anondita Medicare Limited clarified procedures for handling odd lots of Rights Entitlements and shares during its ongoing Rights Issue. No new transaction value is involved.
Anondita Medicare Annual General Meeting
Anondita Medicare Limited has issued the notice for its 3rd Annual General Meeting scheduled for September 29, 2026. The meeting will address ordinary and special business resolutions.
Anondita Medicare H1 FY26 Results: Net Profit ₹13 Cr, Up 116.7% YoY
Anondita Medicare Ltd reported revenue from operations of ₹54.1 Cr (+72.3% YoY) and net profit of ₹13 Cr (+116.7% YoY) for H1 FY26.
- Key figure
- Net profit ₹13 Cr · +116.7% YoY
Anondita Medicare Earnings Call: Key Takeaways
Anondita Medicare reported strong FY26 results with revenue growing 78% YoY to ₹137.42cr and PAT rising 107% to ₹34.30cr. Strategy focuses on high-margin female condoms and international market expansion.